Team Leader, The Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU)
The Institute of Cancer Research
Role Managed by:
Dr Urvashi Ramphul
Senior Research Associate
t: +44 (0) 20 7340 6280
f: +44 (0) 20 7340 6201
Primary Practice Group: Higher Education and Research
Salary & Benefits: Competitive
Closing Date: 24/10/2018
Formal Interview Date: 16th November
The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations, with an outstanding record of achievement dating back more than 100 years. They provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, they are world leaders in discovering new targeted cancer drugs, identifying new cancer genes and developing new forms of precision radiotherapy.
Under the leadership of their Chief Executive and President, Professor Paul Workman FRS, The Institute of Cancer Research (ICR) is ranked as the UK’s leading higher education institution for the quality and impact of its research. Together with their partner, The Royal Marsden NHS Foundation Trust, they are rated in the top four centres for cancer research and treatment worldwide.
The ICR is committed to attracting and developing the best minds in the world to join them in their mission – to make the discoveries that defeat cancer.
ICR-CTSU is a research-led, academic clinical trials unit (CTU) within the Division of Clinical Studies at the ICR. It is a multi-disciplinary CTU, which comprises more than 90 staff, including statisticians, clinical trial programme managers, trial managers, data managers, research IT programmers, and administrative support staff. Specialising in phase II exploratory and phase III randomised trials of new treatments and technologies (including radiotherapy), the ICR-CTSU portfolio includes innovative, efficient and adaptive trial platforms, both national and international, and prioritises trials activity in three clinical and therapeutic domains: breast cancer systemic therapies and uncommon cancers; urological and lung cancer systemic therapies and early phase trials; and image-guided and local therapies.
Following the successful renewal of the CRUK core programme grant in 2018, ICR-CTSU are looking to expand their statistical and methodology leadership team. Based at the Sutton site, the new ICR-funded Career Development Faculty post will take responsibility for a component of the ICR-CTSU portfolio of clinical trials research. S/he will further develop and grow the portfolio in line with the Unit’s overall strategy and take responsibility for a number of ongoing trials as well as the development of new trials.
ICR-CTSU seek an experienced medical statistician with a research interest in clinical trials methodology and a passion for direct involvement in the oversight and leadership of academic clinical trials. The post holder will be expected to make a substantial independent intellectual contribution to clinical trial projects and be proactive in leading and contributing to broad initiatives that enhance the overall effectiveness of ICR-CTSU. In partnership with clinical opinion leaders, s/he will generate research funds to conduct and deliver clinical trials research at the international forefront. S/he will demonstrate the scientific expertise, independent intellectual contribution, creative scientific problem-solving and drive to develop into a future internationally renowned trial methodology leader.
Initial applications should consist of a letter of motivation and a complete curriculum vitae including major achievements, a publication and research funding list and the contact details for three referees. The closing date for applications is Wednesday 24th October.
Applications will be considered by the recruitment committee in late October and shortlisted candidates will subsequently be invited for informal conversations with relevant stakeholders in November. Candidates progressing to formal interview will be required to submit a research proposal (3,000-3,500 words) outlining current research interests and plans for the next five years. Formal interviews and campus visit will follow with selection of and negotiations with the preferred candidate thereafter.